Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase 2, Open-label Study to Evaluate CC-10004 Recalcitrant (Not Responded to Therapy) Plaque-type Psoriasis
This study has been completed.
Study NCT00521339   Information provided by Celgene Corporation
First Received: August 24, 2007   Last Updated: September 28, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Psoriasis
More general conditions related to this trial
Skin Diseases
Skin Diseases, Papulosquamous
Interventions listed in this trial
CC-10004
Sponsors listed in this trial
Celgene Corporation


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services